The emerging treatment of this peptide represents a exciting development in the handling of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide045747.dailyhitblog.com/47739792/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment